Edition:
United Kingdom

FDA Approves Novartis' Piqray, the First Pi3k Inhibitor For Breast Cancer


Friday, 24 May 2019 

May 24 (Reuters) - U.S. Food and Drug Administration::FDA APPROVES FIRST PI3K INHIBITOR FOR BREAST CANCER.FDA APPROVES FIRST PI3K INHIBITOR FOR BREAST CANCER.FDA- ALSO APPROVED COMPANION DIAGNOSTIC TEST, THERASCREEN PIK3CA RGQ PCR KIT, TO DETECT PIK3CA MUTATION IN A TISSUE AND/OR A LIQUID BIOPSY.